the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee (NCT02524509) | Clinical Trial Compass
CompletedNot Applicable
the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee
South Korea21 participantsStarted 2012-01
Plain-language summary
The purpose of this study is to evaluate safety and efficacy of Chondron(autologous cultured Chondrocyte) by comparing between Chondron implantation and Microfracture.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- 1. Patients who underwent autologous chondrocyte implantation using CHONDRON (autologous cultured chondrocyte) or patients underwent microfracture more than 2 years ago.
2\. Patients who meet the above criteria 1, the patient or a guardian agreed to participate in the clinical trial, and signed a written agreement form
Exclusion Criteria:
\- 1. Patients with psychological disease or other patients who are determined to be unsuitable to this clinical trial by the investigators conducting the clinical trial.
2\. Patients who underwent autologous chondrocyte implantation applying CHONDRON (autologous cultured chondrocyte) or microfracture, and the lesion was treated with other procedures subsequently.
What they're measuring
1
Score change of KOOS(Knee Injury and Osteoarthritis Outcome)